In this review:
Rectal tacrolimus for resistant ulcerative proctitis
MRI therapeutic response criteria in CD
Telemedicine personalised care for IBD
Anti-TNF stop week during pregnancy
Impact of hospital travel distance on IBD outcomes
In utero exposure to anti-TNF for IBD
Anti-inflammatory diet effects on intestinal microbiota
Cost-effectiveness of laparoscopic ileocaecal resection vs infliximab
Pooled faecal microbiota transplantation in UC
Outcomes in IBD patients who smoke at diagnosis
Long-term efficacy and safety of ustekinumab for CD
Long-term follow-up of the TAXIT trial
Please login below to download this issue (PDF)